Dong-Wan Kim

Phase I and Pharmacokinetic Study of Genexol-PM, a Cremophor-Free, Polymeric Micelle-Formulated Paclitaxel, in Patients with Advanced Malignancies

Tae‐You Kim, Dong-Wan Kim, Jae‐Yong Chung et al. · Clinical Cancer Research · 2004 · 796 citations

TRAIL sensitize MDR cells to MDR-related drugs by down-regulation of P-glycoprotein through inhibition of DNA-PKcs/Akt/GSK-3β pathway and activation of caspases

Suk-Bin Seo, Jung-Gu Hur, Mi‐Ju Kim et al. · Molecular Cancer · 2010 · 44 citations · Full text

Clinical dissection of multicentric Castleman disease

Dong‐Yeop Shin, Yoon Kyung Jeon, Yong-Sang Hong et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2011 · 39 citations

Clinical Dissection, Gross Anatomy, Surgical Oncology +15

Non-Responders to Intravenous Immunoglobulin and Coronary Artery Dilatation in Kawasaki Disease: Predictive Parameters in Korean Children

Bo Young Kim, Dong-Wan Kim, Yong Hyun Kim et al. · Korean Circulation Journal · 2016 · 39 citations · Full text

Ku70 acetylation and modulation of c-Myc/ATF4/CHOP signaling axis by SIRT1 inhibition lead to sensitization of HepG2 cells to TRAIL through induction of DR5 and down-regulation of c-FLIP

Mi‐Ju Kim, Kyung-Soo Hong, Hak-Bong Kim et al. · The International Journal of Biochemistry & Cell Biology · 2012 · 21 citations

Signal Transduction, Signaling Pathway, Cell Regulation +7